one
import
posttransl
modif
ubiquitin
play
versatil
role
cancerrel
pathway
involv
protein
metabol
cellcycl
progress
apoptosi
transcript
counteract
activ
ligas
deubiquityl
enzym
suggest
anoth
import
mechan
modul
ubiquitin
process
implic
cancer
well
articl
review
emerg
role
cancer
pathway
reveal
recent
studi
discuss
major
mechan
involv
cancerrel
pathway
wherebi
regul
physiolog
homeostasi
ubiquitin
process
dnadamag
respons
cell
cycl
genotox
stress
review
studi
target
treat
multipl
cancer
includ
nonsmal
cell
lung
cancer
breast
cancer
intestin
cancer
glioma
bladder
cancer
result
clinic
signific
target
cancer
therapi
merit
explor
demonstr
addit
develop
pharmacolog
inhibitor
effici
strategi
target
clinic
adapt
feasibl
treat
cancer
one
preval
import
posttransl
modif
ubiquitin
involv
multipl
cancerrel
pathway
includ
cellcycl
progress
apoptosi
receptor
downregul
gene
transcript
antagon
activ
ubiquitin
ligas
deubiquityl
enzym
dub
engag
cancerrel
pathway
modul
ubiquitin
process
open
question
owe
versatil
regul
cell
domin
mechan
impos
given
cancer
type
like
phosphoryl
ubiquitin
one
preval
import
posttransl
modif
found
cell
multifacet
role
normal
patholog
cellular
process
type
modif
ubiquitin
attach
target
protein
coval
isopeptid
bond
cterminu
ubiquitin
lysin
residu
target
protein
implic
ubiquitin
cancerrel
pathway
unveil
recent
year
mostli
relat
cellcycl
progress
apoptosi
receptor
downregul
gene
transcript
three
type
enzym
function
sequenti
add
ubiquitin
substrat
ubiquitinactiv
enzym
catalyz
format
thioester
bond
ubiquitin
ubiquitinconjug
enzym
carri
ubiquitin
final
ligas
attach
ubiquitin
substrat
fig
ubiquitin
first
report
mechan
mark
protein
proteasomemedi
degrad
later
function
ubiquitin
reveal
span
modul
protein
traffick
regul
activ
enzym
appreci
ubiquitin
ligas
central
ubiquitinconjug
system
sinc
directli
interact
substrat
determin
substrat
specif
ligas
implic
cancer
develop
may
dictat
degrad
oncoprotein
tumor
suppressor
exampl
agonist
promot
degrad
cmyc
cyclin
e
tumor
cell
interestingli
act
revers
remov
tag
ubiquitin
substrat
protein
deubiquityl
enzym
dub
implic
import
mechan
modul
ubiquitin
process
well
relat
cancer
dub
human
categor
five
famili
includ
ubiquitinspecif
proteas
usp
ubiquitin
carboxytermin
hydrolas
uch
ovarian
tumorlik
proteas
otu
metalloproteas
machadojakobdiseas
proteas
except
dub
jammmpn
famili
metalloproteas
dub
cystein
proteas
fig
much
knowledg
accumul
function
dub
limit
revers
ubiquitin
protein
tag
proteasom
degrad
known
function
dub
multidimension
encompass
apoptosi
protein
traffick
cell
cycl
regul
dna
damag
repair
chromatin
remodel
modul
signal
pathway
asid
fig
ubiquitin
process
ubiquitin
process
catalyz
three
type
enzym
function
sequenti
ubiquitinactiv
enzym
promot
format
thioester
bond
ctermin
carboxyl
group
ubiquitin
cystein
sulfhydryl
group
step
depend
atp
second
step
ubiquitin
transfer
activ
site
conjug
enzym
last
step
ubiquitin
ligas
catalyz
attach
ubiquitin
substrat
isopeptid
bond
lysin
target
protein
glycin
ubiquitin
enzym
recogn
discrimin
variou
substrat
cell
thu
determin
substrat
specif
given
ubiquitin
process
enzym
typic
carri
either
one
two
domain
structur
homolog
carboxyl
terminu
hect
domain
realli
interest
new
gene
ring
domain
depend
domain
carri
catalyt
mechan
may
differ
catalyt
domain
structur
five
subfamili
deubiquitinas
vari
significantli
usp
uch
mjd
catalyt
domain
share
conserv
residu
around
catalyt
core
otu
domain
lack
conserv
residu
complet
miss
jamm
domain
carbon
gray
nitrogen
blue
oxygen
red
sulfur
orang
zinc
purpl
blue
ribbon
structur
repres
complex
ubiquitin
reproduc
permiss
refer
act
substrat
target
degrad
dub
also
modul
activ
protein
therefor
affect
activ
signal
pathway
instanc
nuclear
pathway
cylindromatosisassoci
dub
cyld
neg
regul
activ
antagon
activ
ligas
tumor
necrosi
factor
receptorassoci
factor
role
variou
dub
cancerassoci
pathway
review
review
focu
discuss
specif
role
cancer
pathway
potenti
therapeut
valu
cancer
treatment
role
cancerrel
pathway
initi
identifi
homolog
search
like
gene
contain
altern
splice
exon
produc
tissuespecif
isoform
enzym
crystal
structur
sever
usp
famili
enzym
resolv
includ
structur
studi
suggest
usp
possess
homolog
catalyt
site
confer
similar
ubiquitinrecognit
mechan
therefor
like
usp
famili
dub
may
share
mechan
recogn
ubiquitin
highli
homolog
contain
ubiquitinassoci
domain
ubiquitininteract
motif
ntermin
region
emerg
role
cancer
pathway
reveal
recent
studi
review
mechan
account
involv
pathway
fig
tabl
henc
demonstr
signific
therapeut
target
cancer
treatment
disrupt
physiolog
homeostasi
ubiquitin
process
first
dub
shrna
screen
use
cmyc
stabil
readout
human
tumor
cell
counteract
activ
promot
cmyc
stabil
cancer
cell
overexpress
inhibit
ubiquitin
cmyc
cyclin
oncoprotein
deplet
cancer
cell
line
phenocopi
effect
myc
deplet
result
requir
cmycmedi
tumor
cell
prolifer
fbox
protein
import
compon
scf
type
ubiquitin
ligas
determin
substrat
specif
scf
complex
consid
tumor
suppressor
control
cell
prolifer
differenti
apoptosi
target
key
transcript
factor
ubiquitindirect
proteasom
degrad
function
counteract
dub
ubiquitin
chain
remov
dub
proteolysi
tag
protein
function
dub
may
cover
wide
rang
physiolog
process
cell
promin
scenario
exemplifi
promot
oncoprotein
stabil
patholog
dysregul
deubiquitin
process
would
lead
deleteri
effect
caus
cancerdriv
oncoprotein
accumul
addit
stabil
also
found
directli
stabil
lead
reduct
substrat
protein
result
contrast
oncogen
effect
overexpress
colorect
cancer
inhibit
delet
would
otherwis
tumorpromot
effect
destabil
rais
interest
question
regard
dual
function
whether
oncogen
tumorsuppress
account
explan
level
vari
consider
differ
cell
influenc
stabil
regul
cell
result
dual
regul
may
serv
mechan
maintain
physiolog
level
protooncogen
substrat
model
may
serv
either
tumor
promotor
suppressor
depend
statu
autocatalyt
ubiquitin
intestin
delet
affect
stabil
attenu
tumorigenesi
tissu
autocatalyt
turnov
favor
delet
resembl
lossoffunct
thu
exhibit
tumorpromot
effect
also
worth
note
addit
aforement
oncogen
protein
substrat
known
associ
also
subject
deubiquitin
stabil
includ
claspin
fact
add
anoth
layer
complex
regard
role
cancerrel
pathway
addit
affect
turnov
critic
oncoprotein
like
myc
may
regul
essenti
pathway
cancer
progress
studi
propos
novel
mechan
upregul
angiogenesi
antagon
glycogen
synthas
degrad
hypoxiainduc
major
regul
angiogenesi
carcinogenesi
variou
process
cell
adapt
hypox
condit
degrad
phosphoryl
recruit
process
revers
overexpress
importantli
stabil
depend
result
reciproc
regul
angiogenesi
metastasi
manner
therefor
modul
function
may
contribut
novel
adapt
mechan
cell
respond
variou
signal
affect
cell
prolifer
differenti
apoptosi
find
offer
altern
way
regul
cancer
pathway
target
cancer
treatment
radiotherapi
complement
surgeri
chemotherapi
despit
develop
plan
applic
radiotherapi
result
improv
cure
rate
challeng
radioresist
radiationinduc
damag
persist
impair
success
radiotherapi
major
effect
radiotherapi
ioniz
damag
caus
dna
base
damag
singl
strand
break
ssb
doubl
strand
break
dsb
occur
cell
exquisit
mechan
sens
repair
dna
damag
pathway
disturb
dysregul
observ
tumor
cell
radioresist
develop
nullifi
therapeut
effort
earli
studi
shown
play
import
role
control
ddr
ddr
signal
sens
initi
phosphatidylinositol
kinas
pikk
atm
atr
transduc
variou
cellular
factor
activ
downstream
checkpoint
kinas
like
pikk
specif
factor
recruit
pikk
differ
form
dna
damag
ie
base
damag
ssb
dsb
regul
activ
checkpoint
mediat
includ
serv
scaffold
pikk
complex
substrat
these
checkpoint
mediat
critic
control
respons
irradi
ir
induc
ddr
initi
identifi
partner
tandem
affin
purif
experi
mechanist
deubiquitin
stabil
specif
factor
mediat
atm
atr
signal
protect
ubiquitinationmedi
proteasom
degrad
regul
factor
mediat
includ
claspin
depend
physic
associ
catalyt
domain
requir
regul
well
dominantneg
mutant
fig
mechan
involv
cancerrel
pathway
upper
panel
counteract
activ
ligas
antagon
fbox
protein
import
compon
scf
type
ubiquitin
ligas
target
key
transcript
factor
ubiquitindirect
proteasom
degrad
result
stabil
import
ligas
substrat
oncogen
cmyc
promot
lead
enhanc
prolifer
carcinogenesi
metastasi
also
upregul
angiogenesi
antagon
glycogen
synthas
degrad
hypoxiainduc
major
regul
angiogenesi
carcinogenesi
variou
process
cell
adapt
hypox
condit
middl
panel
modul
key
factor
dna
damag
respons
wherein
form
complex
antagon
polyubiquitin
proteasom
degrad
consequ
apoptosi
downregul
process
favor
cancer
cell
lower
panel
genotox
stress
induc
drug
ioniz
radiat
render
cell
stall
mitosi
repair
result
dna
damag
stabil
claspin
maintain
arrest
thu
promot
atrmedi
activ
accord
role
checkpoint
signal
claspin
posit
regul
dna
replic
overexpress
enhanc
cell
prolifer
catalyt
cystein
phenocopi
knockdown
cell
therefor
may
restrain
ubiquitinationmedi
proteolysi
compon
ddr
interestingli
anoth
studi
shown
directli
regul
ubiquitin
ligas
protein
domain
interact
mediat
ubiquitinationdirect
proteasom
degrad
form
complex
counteract
neg
regul
although
system
phenotyp
cell
unclear
expect
destabil
knockdown
may
lead
neg
regul
ddr
howev
worth
note
regul
ddr
anoth
layer
involv
multipl
pathway
oppos
function
either
promot
apoptot
death
stabil
factor
pathway
promot
ir
resist
regul
claspin
therefor
effect
surviv
ddr
determin
net
balanc
oppos
pathway
cell
physiolog
milieu
tissueand
cell
typedepend
genotox
stress
induc
either
drug
ir
cell
repair
result
dna
damag
progress
mitosi
shown
maintain
arrest
stabil
claspin
key
regul
claspin
stimul
atrdepend
activ
genotox
stress
stress
reliev
phase
cell
recov
dna
replic
stress
claspin
ubiquitin
degrad
via
scf
therefor
degrad
claspin
serv
mechan
cell
shut
checkpoint
enter
phase
cell
cycl
interestingli
claspin
level
oscil
previou
next
round
transit
thu
subject
activ
degrad
proteolysi
claspin
phase
requir
cell
maintain
state
prevent
prematur
entri
phase
also
parallel
role
checkpoint
signal
claspin
posit
regul
dna
replicationoverexpress
claspin
enhanc
tumor
normal
cell
prolifer
result
like
stabil
claspin
may
implic
cell
cycl
regul
yet
identifi
addit
system
target
claspin
subject
ubiquitin
ligas
rais
anoth
questionwhil
deubiquitinas
activ
requir
revert
ubiquitinationmedi
protein
turnov
discrimin
differ
substrat
remain
elus
answer
question
promot
understand
pathophysiolog
implic
tabl
report
target
antagon
ubiquitindepend
degrad
claspin
deubiquitin
stabil
protein
deubiquitin
stabil
protein
deubiquitin
stabil
protein
deubiquitin
stabil
protein
deubiquitin
stabil
protein
antagon
degrad
regul
genotox
cell
cycl
progress
may
shed
light
improv
strategi
cancer
therapi
target
cancer
therapi
dub
long
target
cancer
treatment
instanc
cyld
member
usp
class
dub
identifi
causal
gene
rare
famili
condit
cylindromatosi
trichoepithelioma
symptom
develop
multipl
skin
tumor
loss
function
cyld
tipto
transcript
activ
pathway
activ
side
drive
mani
oncogen
process
therefor
target
cyld
may
import
signific
treatment
multipl
cancer
lung
liver
colon
multipl
myeloma
melanoma
besid
cyld
addit
dub
includ
implic
potenti
target
variou
cancer
clinic
implic
dysregul
document
variou
cancer
well
result
signific
target
cancer
treatment
drawn
attent
review
advanc
cancer
therapi
tabl
target
nonsmal
cell
lung
cancer
nsclc
suggest
therapeut
target
nsclc
one
studi
found
upregul
nsclc
tumor
importantli
poor
surviv
correl
high
level
patient
cancerpromot
role
confirm
vitro
assay
overexpress
could
enhanc
nsclc
cell
prolifer
downregul
induc
apoptosi
interestingli
may
target
microrna
luciferas
activ
significantli
reduc
differ
studi
howev
identifi
target
cyclin
nsclc
level
lower
nsclc
tumor
match
adjac
normal
tissu
correl
better
clinicopatholog
featur
coincid
upregul
nsclc
tumor
associ
poor
prognosi
nsclc
patient
therefor
may
target
inhibit
nsclc
growth
inde
downregul
concomit
upregul
nsclc
tissu
cell
line
importantli
suppress
prolifer
promot
apoptosi
nsclc
cell
verifi
direct
target
phenotyp
nsclc
cell
prolifer
apoptosi
impos
could
attenu
overexpress
accordingli
therapeut
valu
target
demonstr
vivo
experi
overexpress
inhibit
growth
nsclc
tumor
therefor
may
promis
diagnost
marker
therapeut
target
nsclc
one
studi
reveal
critic
mechan
underli
epigenet
regul
breast
cancer
unbias
sirna
screen
human
dub
yield
bona
fide
deubiquitinas
lysinespecif
demethylas
interact
stabil
clinic
tumor
sampl
overexpress
correl
upregul
interestingli
critic
epigenet
regul
control
pluripot
differenti
demethyl
disrupt
lead
destabil
suppress
cancer
stem
celllik
characterist
vitro
inhibit
tumorigen
vivo
therefor
target
provid
anoth
treatment
approach
breast
cancer
followup
studi
confirm
could
modul
epigenet
event
breast
cancer
histon
deacetylas
hdac
facilit
breast
cancer
prolifer
interestingli
could
promot
stabil
overexpress
larg
revers
protein
degrad
suggest
posit
regul
stabil
therefor
target
may
tune
epigenet
process
drive
breast
cancer
develop
progress
state
previous
stabil
protein
exhibit
oncogen
activ
importantli
highli
express
colon
cancer
make
potenti
pharmacolog
target
control
cmycdriv
tumor
cell
mous
model
colorect
cancer
contrast
phenotyp
intestinespecif
delet
reduc
intestin
tumor
importantli
mice
carri
tumor
delet
reduc
tumor
size
prolong
lifespan
interestingli
also
antagon
ubiquitindepend
degrad
two
addit
oncogen
protein
cjun
expand
substrat
list
share
therapeut
benefit
colon
cancer
demonstr
anoth
studi
knockout
could
increas
life
expect
anim
harbor
colon
tumor
consist
substrat
includ
cmyc
cjun
cyclin
upregul
mice
downregul
doubleknockout
mous
upregul
correl
poor
overal
surviv
prognosi
nsclc
patient
remain
determin
microrna
target
nsclc
detail
main
text
exact
mechan
promot
nsclc
cell
prolifer
undetermin
yet
breast
cancer
stabil
critic
chromatin
modul
control
cell
pluripot
differenti
deubiquitin
requir
maintain
cancer
stem
cell
csc
like
characterist
addit
mechan
suggest
histon
deacetylas
promot
stabil
thu
enhanc
stabil
overexpress
posit
correl
breast
tumor
intestin
cancer
promot
deubiquitin
import
oncogen
protein
includ
cmyc
cjun
thu
stabil
intestin
function
independ
ligas
intestin
crypt
stem
cell
preval
overexpress
human
colorect
carcinoma
also
enhanc
intestin
tumorigenesi
glioma
stimul
glioma
cell
prolifer
vitro
vivo
cmyc
upregul
may
contribut
glioma
tumorigenec
level
posit
correl
glioma
grade
invers
correl
patient
surviv
mechan
remain
unclear
posit
regul
cmyc
human
glioma
bladder
cancer
remain
unclear
role
bladder
cancer
upregul
significantli
correl
bladder
cancer
grade
stage
recurr
knowledg
role
bladder
cancer
limit
target
glioma
signific
glioma
tumorigenesi
demonstr
posit
regul
myc
dysregul
major
glioma
difficult
target
directli
determin
upregul
human
glioma
normal
brain
tissu
protein
level
human
glioma
tissu
directli
correl
glioma
grade
invers
correl
patient
surviv
ectop
express
promot
prolifer
glioma
cell
vitro
vivo
confer
enhanc
tumorigen
nude
mous
model
disrupt
glioblastoma
cell
suppress
anchorageindepend
growth
vitro
tumorigen
vivo
importantli
promot
myc
express
requir
cell
growth
human
glioma
therefor
could
new
target
therapi
human
malign
glioma
clinic
signific
also
demonstr
human
bladder
cancer
determin
overexpress
bladder
cancer
compar
adjac
noncancer
tissu
mrna
protein
level
ihc
examin
confirm
major
cancer
tissu
display
high
level
furthermor
strongli
correl
histopatholog
grade
clinic
stage
tumor
number
recurr
rate
interestingli
express
level
serv
independ
predictor
surviv
therefor
potenti
valuabl
prognost
evalu
bladder
cancer
date
pharmacolog
studi
dub
focus
screen
identifi
novel
dub
inhibitor
antagonist
clinic
regiment
use
high
throughput
screen
chemic
librari
follow
structuralact
relationship
studi
yield
fruit
compound
exhibit
select
particular
dub
due
import
role
stabil
small
molecul
select
focu
pharmacolog
studi
dub
hbx
discov
inhibit
activ
submicromolar
rang
treatment
compound
lead
stabil
subsequ
repress
cancer
cell
growth
dual
inhibitor
select
also
report
promot
apoptosi
cancer
cell
efficaci
document
mous
xenograft
model
myeloma
bcell
leukemia
tabl
list
major
usp
inhibitor
howev
despit
advanc
dubtarget
drug
discoveri
identifi
compound
still
earli
stage
await
clinic
approv
date
compound
target
report
yet
dubtarget
drug
yet
approv
ubiquitin
one
import
posttransl
modif
observ
cell
play
multifacet
role
cellular
pathway
affect
protein
turnov
signal
respons
variou
stress
dub
remov
ubiquitin
tag
shown
regul
stabil
signal
protein
turn
affect
output
varieti
signal
cascad
control
cell
prolifer
surviv
dna
damag
respons
carcinogenesi
metastasi
sever
dub
target
therapeut
applic
exemplifi
promis
drug
discoveri
studi
date
major
role
demonstr
regul
ddr
ubiquitinationdepend
proteolysi
pathway
like
function
celltissu
typedepend
particular
system
specif
aspect
function
domin
regardless
may
potenti
benefici
therapeut
target
cancer
treatment
henc
clinic
related
applic
extens
explor
investig
evalu
